Why Preprints Need Extra Caution in Health News
Unvetted health research spreads faster than expert correction. Here's why you should read with caution.
Category Blog/News
Why Sample Size Matters in Alzheimer’s News
Small Alzheimer's studies can miss real treatment effects—here's why sample size shapes what research actually proves.
How Alzheimer’s News Moves Biotech Stocks
A single Alzheimer's drug approval or failed trial can shift a biotech company's market value by billions of dollars in minutes.
Why Dementia News Needs Context and Caution
Media coverage of dementia research often amplifies preliminary findings and overstates clinical significance, misleading families about treatments and risks.
Can Local News Turn Dementia Research Into Public Awareness?
Local news has proven it can raise awareness about dementia research, but coverage gaps mean millions still don't know about preventive strategies and new diagnostic tools.
Can Alzheimer’s News Help Build Better Blog Topics?
Yes, Alzheimer's news can significantly help build better blog topics—especially if you understand what stories matter most to readers and how emerging...
What Dementia News Readers Should Remember
When reading dementia news, the most important thing to remember is that statistics can mask individual stories—and individual stories can mislead you...
How to Avoid Panic After Reading Alzheimer’s News
You can avoid panic after reading Alzheimer's news by understanding that alarming headlines often lack nuance, remembering that most people who read about...
Can News About Risk Factors Create Unnecessary Fear?
Yes, news about risk factors can absolutely create unnecessary fear—and the evidence suggests this is happening at a significant scale.
Why Caffeine Research Keeps Showing Up in Dementia News
Caffeine keeps showing up in dementia news because the evidence for its protective effect is becoming harder to ignore.